|Day Low/High||100.49 / 102.50|
|52 Wk Low/High||64.72 / 125.59|
Readers will decide who takes home the award for the Best Biotech CEO of 2010. Vote now!
Drug approvals, clinical trial wins and sales growth helped stocks like Amarin and Questcor to more than double this year.
Neurocrine CEO Discusses Q3 2010 Results - Earnings Call Transcript
Several stocks trading below $5, including Harbor BioSciences, were poised to move on above-average volume Wednesday.
Neurocrine Biosciences, Inc. Q2 2010 Earnings Call Transcript
Several stocks, including Discovery Labs, were poised to move on above-average volume Thursday.
Abbott gains worldwide rights to elagolix for the treatment of endometriosis.
Abbott Labs and Neurocrine Biosciences will jointly develop and commercialize elagolix for the treatment of endometriosis-related pain.
Several stocks trading near $5, including Javelin Pharmaceuticals, were moving on above-average volume Thursday.
Several stocks trading near $5, including Hanmi Financial, were moving on above-average volume Wednesday.
EMC, Beazer Homes, AutoZone, DiamondRock Hospitality among big market movers Tuesday
Several stocks trading near $5, including Sprint, were poised to move on above-average volume Tuesday.
Neurocrine Biosciences Inc. Q1 2010 Earnings Call Transcript
Several stocks trading near $5 were moving on above-average volume during Friday's session.
Patients treated for endometriosis with elagolix reported improved daily pelvic pain scores compared with placebo, but the difference wasn't statistically significant.
Senior Writer Adam Feuerstein provides a list of biotech and drug clinical trials expected to move stocks in 2009.
Scores of smaller biotech firms have unpartnered drugs in the pipeline, making them ripe for alliances or takeovers.
The centerpiece of the newly combined company is Gencaro, an unimpressive heart failure drug.
The FDA again asks for more data on sleep-aid drug Indiplon.
Cephalon slumps after posting lower-than-expected quarterly numbers.
Nerocrine Biosciences was among the late movers Tuesday in light trading.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.